The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Resveratrol Treatment of Mice With Pressure-Overload–Induced Heart Failure Improves Diastolic Function and Cardiac Energy Metabolism
Open accessAbstract
Background—: Although resveratrol has multiple beneficial cardiovascular effects, whether resveratrol can be used for the treatment and management of heart failure (HF) remains unclear. In the current study, we determined whether resveratrol treatment of mice with established HF could lessen the detrimental phenotype associated with pressure-overload–induced HF and identified physiological and molecular mechanisms contributing to this. Methods and Results—: C57Bl/6 mice were subjected to either sham or transverse aortic constriction surgery to induce HF. Three weeks post surgery, a cohort of mice with established HF (% ejection fraction <45) was administered resveratrol (≈320 mg/kg per day). Despite a lack of improvement in ejection fraction, resveratrol treatment significantly increased median survival of mice with HF, lessened cardiac fibrosis, reduced gene expression of several disease markers for hypertrophy and extracellular matrix remodeling that were upregulated in HF, promoted beneficial remodeling, and improved diastolic function. Resveratrol treatment of mice with established HF also restored the levels of mitochondrial oxidative phosphorylation complexes, restored cardiac AMP-activated protein kinase activation, and improved myocardial insulin sensitivity to promote glucose metabolism and significantly improved myocardial energetic status. Finally, noncardiac symptoms of HF, such as peripheral insulin sensitivity, vascular function, and physical activity, were improved with resveratrol treatment. Conclusions—: Resveratrol treatment of mice with established HF lessens the severity of the HF phenotype by lessening cardiac fibrosis, improving molecular and structural remodeling of the heart, and enhancing diastolic function, vascular function, and energy metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mice supplemented with resveratrol exhibit prolonged survival, less frequently occurring cardiac fibrosis, and improved diastolic function (Sung et al. 2015).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Sung et al. 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Cardiac Hypertrophy: The Good, the Bad, and the Ugly
Frey, N., & Olson, E. N. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142243 · Cited by 1,480
Franciosa, J. A., Park, M., & Levine, T. B. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90286-1 · Cited by 878
Yu, C., Bleeker, G. B., Fung, J. W., Schalij, M. J., Zhang, Q., van der Wall, E. E., Chan, Y. S., Kong, S., & Bax, J. J. (2005) · Circulation · doi:10.1161/circulationaha.105.538272 · Cited by 706
Konstam, M. A., Rousseau, M. F., Kronenberg, M. W., Udelson, J. E., Melin, J., Stewart, D., Dolan, N., Edens, T. R., Ahn, S. A., & Kinan, D. (1992) · Circulation · doi:10.1161/01.cir.86.2.431 · Cited by 605
Molecular Pathways Underlying Cardiac Remodeling During Pathophysiological Stimulation
Kehat, I., & Molkentin, J. D. (2010) · Circulation · doi:10.1161/circulationaha.110.942268 · Cited by 592
Endothelial Dysfunction, Arterial Stiffness, and Heart Failure
Marti, C. N., Gheorghiade, M., Kalogeropoulos, A. P., Georgiopoulou, V. V., Quyyumi, A. A., & Butler, J. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.11.082 · Cited by 500
Zhong, J., Basu, R., Guo, D., Chow, F. L., Byrns, S., Schuster, M., Loibner, H., Wang, X., Penninger, J. M., Kassiri, Z., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.955369 · Cited by 455
Self-citationSaddik, M., & Lopaschuk, G. D. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92956-x · Cited by 427
Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart
Creemers, E. E., & Pinto, Y. M. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq308 · Cited by 408
Segura, A. M., Frazier, O. H., & Buja, L. M. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9365-4 · Cited by 379
Healing after myocardial infarction
Ertl, G., & Frantz, S. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.01.011 · Cited by 311
Doehner, W., Rauchhaus, M., Ponikowski, P., Godsland, I. F., von Haehling, S., Okonko, D. O., Leyva, F., Proudler, A. J., Coats, A. J. S., & Anker, S. D. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.093 · Cited by 294
Wong, R. H. X., Howe, P. R. C., Buckley, J. D., Coates, A. M., Kunz, I., & Berry, N. M. (2011) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.03.003 · Cited by 277
Zhang, L., Jaswal, J. S., Ussher, J. R., Sankaralingam, S., Wagg, C. S., Zaugg, M., & Lopaschuk, G. D. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.000228 · Cited by 273
Small Animal Models of Heart Failure
Patten, R. D., & Hall-Porter, M. R. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.839761 · Cited by 262
Ventricular-Arterial Coupling, Remodeling, and Prognosis in Chronic Heart Failure
Ky, B., French, B. C., Khan, A. M., Plappert, T. J., Wang, A., Chirinos, J. A., Fang, J. C., Sweitzer, N. K., Borlaug, B. A., Kass, D. A., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.085 · Cited by 248
Resveratrol Prevents the Prohypertrophic Effects of Oxidative Stress on LKB1
Dolinsky, V. W., Chan, A. Y. M., Frayne, I. R., Light, P. E., Rosiers, C. D., & Dyck, J. R. B. (2009) · Circulation · doi:10.1161/circulationaha.108.787440 · Cited by 237
Self-citationHaykowsky, M. J., Timmons, M. P., Kruger, C., McNeely, M. L., Taylor, D. A., & Clark, A. M. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.01.303 · Cited by 224
Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice
Dolinsky, V. W., Chakrabarti, S., Pereira, T. J., Oka, T., Levasseur, J. L., Beker, D. L., Zordoky, B. N. M., Morton, J. S., Nagendran, J., Lopaschuk, G. D., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.018 · Cited by 209
Self-citationAbnormal Mitochondrial Respiration in Failed Human Myocardium
Sharov, V. G., Todor, A. V., Silverman, N. A., Goldstein, S., & Sabbah, H. N. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1266 · Cited by 205
Kaga, S., Zhan, L., MATSUMOTO, M., & Maulik, N. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.08.003 · Cited by 199
Polyakova, V. O., Hein, S., Sawa Kostin, D., Ziegelhoeffer, T., & Schaper, J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.023 · Cited by 196
Momken, I., Stevens, L., Bergouignan, A., Desplanches, D., Rudwill, F., Chery, I., Zahariev, A., Zahn, S., Stein, T. P., Sebedio, J. L., et al. (2011) · The FASEB Journal · doi:10.1096/fj.10-177295 · Cited by 181
Dolinsky, V. W., Jones, K. E., Sidhu, R. S., Haykowsky, M. J., Czubryt, M. P., Gordon, T., & Dyck, J. R. B. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.230490 · Cited by 180
Self-citationRossi, A., Temporelli, P. L., Quintana, M., Dini, F. L., Ghio, S., Hillis, G. S., Klein, A. L., Marsan, N. A., Prior, D., Yu, C., et al. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp112 · Cited by 173
Total-body and myocardial substrate oxidation in congestive heart failure
Paolisso, G., Gambardella, A., Galzerano, D., D’Amore, A., Rubino, P., Verza, M., Teasuro, P., Varricchio, M., & D’Onofrio, F. (1994) · Metabolism · doi:10.1016/0026-0495(94)90241-0 · Cited by 166
Matsusaka, H., Ide, T., Matsushima, S., Ikeuchi, M., Kubota, T., Sunagawa, K., Kinugawa, S., & Tsutsui, H. (2006) · Hypertension · doi:10.1161/01.hyp.0000208840.30778.00 · Cited by 159
Kanamori, H., Takemura, G., Goto, K., Tsujimoto, A., Ogino, A., Takeyama, T., Kawaguchi, T., Watanabe, T., Morishita, K., Kawasaki, M., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.11.009 · Cited by 156
Dai, D., Hsieh, E. J., Chen, T., Menendez, L. G., Basisty, N., Tsai, L., Beyer, R. P., Crispin, D. A., Shulman, N., Szeto, H. H., et al. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000406 · Cited by 151
Zhabyeyev, P., Gandhi, M., Mori, J., Basu, R., Kassiri, Z., Clanachan, A. S., Lopaschuk, G. D., & Oudit, G. Y. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs424 · Cited by 151
Self-citationRimbaud, S., Ruiz, M., Piquereau, J., Matéo, P., Fortin, D., Veksler, V., Garnier, A., & Ventura‐Clapier, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026391 · Cited by 149
Ezekowitz, J. A., Kaul, P., Bakal, J. A., Quan, H., & McAlister, F. A. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq185 · Cited by 143
Hemodynamic Determinants of Exercise Capacity in Chronic Heart Failure
MYERS, J. N., & Froelicher, V. F. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-377 · Cited by 142
Dolinsky, V. W., Rogan, K. J., Sung, M. M., Zordoky, B. N., Haykowsky, M. J., Young, M. E., Jones, L. W., & Dyck, J. R. B. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00044.2013 · Cited by 133
Self-citationContribution of Glycogen to Aerobic Myocardial Glucose Utilization
Longnus, S., Wambolt, R. B., Schönekess, B. O., Lopaschuk, G. D., & Allard, M. F. (1996) · Circulation · doi:10.1161/01.cir.93.8.1549 · Cited by 127
Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure
Gu, X. S., Wang, Z., Ye, Z., Lei, J., Li, L., Su, D., & Zheng, X. (2014) · Genetics and Molecular Research · doi:10.4238/2014.january.17.17 · Cited by 123
Rush, J. W. E., Quadrilatero, J., Levy, A. S., & Ford, R. J. (2007) · Experimental Biology and Medicine · doi:10.3181/00379727-232-2320814 · Cited by 115
Kienesberger, P. C., Pulinilkunnil, T., Sung, M. M. Y., Nagendran, J., Haemmerle, G., Kershaw, E. E., Young, M. E., Light, P. E., Oudit, G. Y., Zechner, R., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.06470-11 · Cited by 111
Self-citationMandic, S., Tymchak, W. J., Kim, D., Daub, B., Quinney, H. A., Taylor, D. A., Al-Kurtass, S., & Haykowsky, M. J. (2009) · Clinical Rehabilitation · doi:10.1177/0269215508095362 · Cited by 107
AlZadjali, M. A., Godfrey, V., Khan, F., Choy, A. M., Doney, A. S. F., Wong, A., Petrie, J. R., Struthers, A. D., & Lang, C. C. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.081 · Cited by 106
Regression of pressure overload-induced left ventricular hypertrophy in mice
Gao, X., Kiriazis, H., Moore, X., Feng, X., Sheppard, K. E., Dart, A. M., & Du, X. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00836.2004 · Cited by 90
Fukuta, H., & Little, W. C. (2006) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2006.08.009 · Cited by 85
No Rest for the Weary: Diastolic Calcium Homeostasis in the Normal and Failing Myocardium
Louch, W. E., Stokke, M. K., Sjaastad, I., Christensen, G., & Sejersted, O. M. (2012) · Physiology · doi:10.1152/physiol.00021.2012 · Cited by 82
Cardiomyocyte-specific ablation of CD36 improves post-ischemic functional recovery
Nagendran, J., Pulinilkunnil, T., Kienesberger, P. C., Sung, M. M. Y., Fung, D., Febbraio, M., & Dyck, J. R. B. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.07.020 · Cited by 78
Self-citationMeta-analysis Research Group in Echocardiography (MeRGE) Heart Failure Collaborators (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.06.005 · Cited by 77
Dolinsky, V. W., Rueda‐Clausen, C. F., Morton, J. S., Davidge, S. T., & Dyck, J. R. B. (2011) · Diabetes · doi:10.2337/db11-0374 · Cited by 74
Self-citationConraads, V. M., Craenenbroeck, E. M. V., Maeyer, C. D., Berendoncks, A. M. V., Beckers, P. J., & Vrints, C. J. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9324-0 · Cited by 62
Gardin, J. M., Leifer, E., Fleg, J. L., Whellan, D. J., Kokkinos, P. F., Leblanc, M.-H., Wolfel, E. E., & Kitzman, D. W. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.07.015 · Cited by 59
Xuan, W., Wu, B., Chen, C., Chen, B., Zhang, W., Xu, D., Bin, J., & Liao, Y. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31825fd7da · Cited by 58
Vascular dysfunction and heart failure: Epiphenomenon or etiologic agent?
Fang, Z. Y., & Marwick, T. H. (2002) · American Heart Journal · doi:10.1067/mhj.2002.120780 · Cited by 54
Vuckovic, K. M., Piano, M. R., & Phillips, S. A. (2013) · Heart Lung and Circulation · doi:10.1016/j.hlc.2012.12.006 · Cited by 27
Bussoni, M., Guirado, G., Roscani, M., Polegato, B., Matsubara, L., Bazan, S., & Matsubara, B. B. (2013) · Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · doi:10.1590/1414-431x20132902 · Cited by 18
Cited by
Sorted by citations
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Cardiac Energy Metabolism in Heart Failure
Lopaschuk, G. D., Karwi, Q. G., Tian, R., Wende, A. R., & Abel, E. D. (2021) · Circulation Research · doi:10.1161/circresaha.121.318241 · Cited by 1,458
Oxidative Stress in Cardiovascular Diseases
Dubois‐Deruy, E., Peugnet, V., Turkieh, A., & Pinet, F. (2020) · Antioxidants · doi:10.3390/antiox9090864 · Cited by 694
Loss of Metabolic Flexibility in the Failing Heart
Karwi, Q. G., Uddin, G. M., Ho, K. L., & Lopaschuk, G. D. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00068 · Cited by 452
Byrne, N. J., Matsumura, N., Maayah, Z. H., Ferdaoussi, M., Takahara, S., Darwesh, A. M., Levasseur, J. L., Jahng, J. W. S., Vos, D. Y., Parajuli, N., et al. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.119.006277 · Cited by 265
Self-citation
Metadata
- Authors
- Sung, M. M., Das, S. K., Levasseur, J., Byrne, N. J., Fung, D., Kim, T. T., Masson, G., Boisvenue, J., Soltys, C.-L., Oudit, G. Y., & Dyck, J. R. B.
- Affiliations
- University of Alberta (CA)
- ORCID
- Venue
- Circulation: Heart Failure
- Published
- 2015-01
- Volume
- 8
- Issue
- 1
- Pages
- 128-137
- ISSN
- 1941-3289 (ISSN-L)
- 1941-3297
- OpenAlex
- W2156697471
- Cited by
- 102
- References
- 53
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 5 · 2023: 7 · 2022: 9 · 2021: 12 · 2020: 10 · 2019: 8 · 2018: 10 · 2017: 10 · 2016: 9 · 2015: 8
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation Heart Failure (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alberta Innovates
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- resveratrol, heart failure, pressure overload, transverse aortic constriction, diastolic function, myocardial fibrosis, cardiac remodeling, cardiac hypertrophy, extracellular matrix remodeling, mitochondrial oxidative phosphorylation, AMPK, myocardial energy metabolism, peripheral insulin sensitivity, vascular function, survival
- MeSH terms
- Resveratrol, Animals, Disease Models, Animal, Energy Metabolism, Male, Mice, Inbred C57BL, Myocardial Contraction, Myocardium, Ribonucleotide Reductases, Stilbenes, Stroke Volume, Vasodilator Agents, Ventricular Function, Left, Ventricular Remodeling, Mice, Heart Failure, Diastolic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
